{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T01:41:42Z","timestamp":1789177302347,"version":"build-2803163510"},"reference-count":67,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Anaesthesiology"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.bpa.2020.11.004","type":"journal-article","created":{"date-parts":[[2020,11,14]],"date-time":"2020-11-14T07:47:50Z","timestamp":1605340070000},"page":"759-769","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["The next generation of antiemetics for the management of postoperative nausea and vomiting"],"prefix":"10.1016","volume":"34","author":[{"given":"Hon Sen","family":"Tan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geertrui","family":"Dewinter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashraf S.","family":"Habib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bpa.2020.11.004_bib1","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1093\/bja\/aes276","article-title":"Evidence-based analysis of risk factors for postoperative nausea and vomiting","volume":"109","author":"Apfel","year":"2012","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bpa.2020.11.004_bib2","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1097\/00000542-199909000-00022","article-title":"A\u00a0simplified risk score for predicting postoperative nausea and vomiting: conclusions from cross-validations between two centers","volume":"91","author":"Apfel","year":"1999","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bpa.2020.11.004_bib3","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1213\/ANE.0000000000004833","article-title":"4th consensus guidelines for the management of postoperative nausea and vomiting","volume":"131","author":"Gan","year":"2020","journal-title":"Anesth Analg"},{"key":"10.1016\/j.bpa.2020.11.004_bib4","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1093\/oxfordjournals.bja.a013383","article-title":"Patient satisfaction after anaesthesia and surgery: results of a prospective survey of 10,811 patients","volume":"84","author":"Myles","year":"2000","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bpa.2020.11.004_bib5","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.ajog.2018.08.006","article-title":"Guidelines for intraoperative care in cesarean delivery: enhanced Recovery after surgery society recommendations (Part 2)","volume":"219","author":"Caughey","year":"2018","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.bpa.2020.11.004_bib6","first-page":"CD012859","article-title":"Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis","volume":"10","author":"Weibel","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.bpa.2020.11.004_bib7","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ejphar.2009.10.002","article-title":"Palonosetron triggers 5-HT(3) receptor internalization and causes prolonged inhibition of receptor function","volume":"626","author":"Rojas","year":"2010","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bpa.2020.11.004_bib8","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1213\/ane.0b013e31817abcd3","article-title":"A\u00a0randomized, double-blind study to evaluate the efficacy and safety of three different doses of palonosetron versus placebo in preventing postoperative nausea and vomiting over a 72-hour period","volume":"107","author":"Kovac","year":"2008","journal-title":"Anesth Analg"},{"key":"10.1016\/j.bpa.2020.11.004_bib9","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1213\/ane.0b013e31817b5ebb","article-title":"A\u00a0randomized, double-blind study to evaluate the efficacy and safety of three different doses of palonosetron versus placebo for preventing postoperative nausea and vomiting","volume":"107","author":"Candiotti","year":"2008","journal-title":"Anesth Analg"},{"key":"10.1016\/j.bpa.2020.11.004_bib10","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.jclinane.2016.05.018","article-title":"Efficacy of palonosetron in postoperative nausea and vomiting (PONV)-a meta-analysis","volume":"34","author":"Singh","year":"2016","journal-title":"J\u00a0Clin Anesth"},{"key":"10.1016\/j.bpa.2020.11.004_bib11","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1007\/s12630-015-0457-1","article-title":"Efficacy of palonosetron for preventing postoperative nausea and vomiting: a systematic review and meta-analysis","volume":"62","author":"Xiong","year":"2015","journal-title":"Can J Anaesth"},{"key":"10.1016\/j.bpa.2020.11.004_bib12","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/1471-2253-14-68","article-title":"Palonosetron and aprepitant for the prevention of postoperative nausea and vomiting in patients indicated for laparoscopic gynaecologic surgery: a double-blind randomised trial","volume":"14","author":"Moon","year":"2014","journal-title":"BMC Anesthesiol"},{"key":"10.1016\/j.bpa.2020.11.004_bib13","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/MJT.0b013e318209dff1","article-title":"A\u00a0randomized double blind study to evaluate efficacy of palonosetron with dexamethasone versus palonosetron alone for prevention of postoperative and postdischarge nausea and vomiting in subjects undergoing laparoscopic surgeries with high emetogenic risk","volume":"19","author":"Blitz","year":"2012","journal-title":"Am J Therapeut"},{"key":"10.1016\/j.bpa.2020.11.004_bib14","doi-asserted-by":"crossref","first-page":"334","DOI":"10.4097\/kjae.2012.63.4.334","article-title":"The comparative study to evaluate the effect of palonosetron monotherapy versus palonosetron with dexamethasone combination therapy for prevention of postoperative nausea and vomiting","volume":"63","author":"Park","year":"2012","journal-title":"Korean J Anesthesiol"},{"key":"10.1016\/j.bpa.2020.11.004_bib15","doi-asserted-by":"crossref","first-page":"322","DOI":"10.4103\/aer.AER_183_17","article-title":"Comparison of palonosetron, dexamethasone, and palonosetron plus dexamethasone as prophylactic antiemetic and antipruritic drug in patients receiving intrathecal morphine for lower segment cesarean section","volume":"12","author":"Swaro","year":"2018","journal-title":"Anesth Essays Res"},{"key":"10.1016\/j.bpa.2020.11.004_bib16","doi-asserted-by":"crossref","first-page":"978","DOI":"10.4103\/ija.IJA_317_17","article-title":"Comparison of efficacy of palonosetron-dexamethasone combination with palonosetron or dexamethasone alone for prophylaxis against post-operative nausea and vomiting in patients undergoing laparoscopic cholecystectomy","volume":"61","author":"Chatterjee","year":"2017","journal-title":"Indian J Anaesth"},{"key":"10.1016\/j.bpa.2020.11.004_bib17","doi-asserted-by":"crossref","first-page":"961","DOI":"10.7150\/ijms.24230","article-title":"Efficacy of palonosetron-dexamethasone combination versus palonosetron alone for preventing nausea and vomiting related to opioid-based analgesia: a prospective, randomized, double-blind trial","volume":"15","author":"Cho","year":"2018","journal-title":"Int J Med Sci"},{"key":"10.1016\/j.bpa.2020.11.004_bib18","first-page":"1685","article-title":"Efficacy and safety of palonosetron for the prophylaxis of chemotherapy-induced nausea and vomiting (CINV): a systematic review and meta-analysis of randomized controlled trials","volume":"22","author":"Popovic","year":"2014","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.bpa.2020.11.004_bib19","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1254\/jjp.78.381","article-title":"Comparative study of ramosetron and granisetron binding in the cloned human 5-hydroxytryptamine-3 receptors","volume":"78","author":"Akuzawa","year":"1998","journal-title":"Jpn J Pharmacol"},{"key":"10.1016\/j.bpa.2020.11.004_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0186006","article-title":"Comparative efficacy of ramosetron and ondansetron in preventing postoperative nausea and vomiting: an updated systematic review and meta-analysis with trial sequential analysis","volume":"12","author":"Yokoi","year":"2017","journal-title":"PloS One"},{"key":"10.1016\/j.bpa.2020.11.004_bib21","first-page":"4591","article-title":"Comparison of ramosetron and ondansetron for the prevention of postoperative nausea and vomiting in patients undergoing laparoscopic surgery: a meta-analysis of randomized controlled trials","volume":"47","author":"Li","year":"2019","journal-title":"J\u00a0Int Med Res"},{"key":"10.1016\/j.bpa.2020.11.004_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0168509","article-title":"Palonosetron and ramosetron compared for effectiveness in preventing postoperative nausea and vomiting: a systematic review and meta-analysis","volume":"11","author":"Ahn","year":"2016","journal-title":"PloS One"},{"key":"10.1016\/j.bpa.2020.11.004_bib23","doi-asserted-by":"crossref","first-page":"848","DOI":"10.3349\/ymj.2017.58.4.848","article-title":"Efficacy of palonosetron vs. Ramosetron for the prevention of postoperative nausea and vomiting: a meta-analysis of randomized controlled trials","volume":"58","author":"Kim","year":"2017","journal-title":"Yonsei Med J"},{"key":"10.1016\/j.bpa.2020.11.004_bib24","doi-asserted-by":"crossref","first-page":"601","DOI":"10.2147\/TCRM.S159211","article-title":"Comparison of ramosetron and ondansetron for the treatment of established postoperative nausea and vomiting after laparoscopic surgery: a prospective, randomized, double-blinded multicenter trial","volume":"14","author":"Choi","year":"2018","journal-title":"Therapeut Clin Risk Manag"},{"key":"10.1016\/j.bpa.2020.11.004_bib25","doi-asserted-by":"crossref","first-page":"144","DOI":"10.4103\/0019-5049.199851","article-title":"Intravenous palonosetron compared with a combination of ramosetron and dexamethasone in preventing post operative nausea and vomiting in patients undergoing gynaecological surgeries under spinal anaesthesia, a randomised study","volume":"61","author":"Narayanappa","year":"2017","journal-title":"Indian J Anaesth"},{"key":"10.1016\/j.bpa.2020.11.004_bib26","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1080\/17512433.2020.1750366","article-title":"A\u00a0pharmacological profile of intravenous amisulpride for the treatment of postoperative nausea and vomiting","volume":"13","author":"Fox","year":"2020","journal-title":"Expert Rev Clin Pharmacol"},{"key":"10.1016\/j.bpa.2020.11.004_bib27","series-title":"Highlights of prescribing information - amisulpride","year":"2020"},{"key":"10.1016\/j.bpa.2020.11.004_bib28","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1080\/14656566.2020.1714029","article-title":"An overview of intravenous amisulpride as a new therapeutic option for the prophylaxis and treatment of postoperative nausea and vomiting","volume":"21","author":"Smyla","year":"2020","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.bpa.2020.11.004_bib29","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1093\/bja\/aet251","article-title":"I.V. APD421 (amisulpride) prevents postoperative nausea and vomiting: a randomized, double-blind, placebo-controlled, multicentre trial","volume":"111","author":"Kranke","year":"2013","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bpa.2020.11.004_bib30","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1097\/ALN.0000000000002133","article-title":"Amisulpride prevents postoperative nausea and vomiting in patients at high risk: a randomized, double-blind, placebo-controlled trial","volume":"128","author":"Kranke","year":"2018","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bpa.2020.11.004_bib31","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1007\/s00228-020-02869-1","article-title":"Efficacy of amisulpride on postoperative nausea and vomiting: a systematic review and meta-analysis","volume":"76","author":"Zhang","year":"2020","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.bpa.2020.11.004_bib32","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1213\/ANE.0000000000003733","article-title":"Randomized, double-blind, placebo-controlled study of intravenous amisulpride as treatment of established postoperative nausea and vomiting in patients who have had No prior prophylaxis","volume":"128","author":"Candiotti","year":"2019","journal-title":"Anesth Analg"},{"key":"10.1016\/j.bpa.2020.11.004_bib33","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/ALN.0000000000002509","article-title":"Amisulpride for the rescue treatment of postoperative nausea or vomiting in patients failing prophylaxis: a randomized, placebo-controlled phase III trial","volume":"130","author":"Habib","year":"2019","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bpa.2020.11.004_bib34","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jclinane.2007.08.003","article-title":"The use of droperidol before and after the Food and Drug Administration black box warning: a survey of the members of the Society of Ambulatory Anesthesia","volume":"20","author":"Habib","year":"2008","journal-title":"J\u00a0Clin Anesth"},{"key":"10.1016\/j.bpa.2020.11.004_bib35","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/ALN.0000000000001458","article-title":"Intravenous amisulpride for the prevention of postoperative nausea and vomiting: two concurrent, randomized, double-blind, placebo-controlled trials","volume":"126","author":"Gan","year":"2017","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bpa.2020.11.004_bib36","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/00004850-199907000-00002","article-title":"Safety of amisulpride (Solian): a review of 11 clinical studies","volume":"14","author":"Coulouvrat","year":"1999","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.bpa.2020.11.004_bib37","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/bcp.13128","article-title":"Thorough QT study of the effect of intravenous amisulpride on QTc interval in Caucasian and Japanese healthy subjects","volume":"83","author":"Taubel","year":"2017","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.bpa.2020.11.004_bib38","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1080\/17512433.2019.1621162","article-title":"Neurokinin-1 receptor antagonists: review of their role for the prevention of chemotherapy-induced nausea and vomiting in adults","volume":"12","author":"Karthaus","year":"2019","journal-title":"Expert Rev Clin Pharmacol"},{"key":"10.1016\/j.bpa.2020.11.004_bib39","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1046\/j.1460-9568.2003.02600.x","article-title":"Neurokinin 1 receptor and relative abundance of the short and long isoforms in the human brain","volume":"17","author":"Caberlotto","year":"2003","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.bpa.2020.11.004_bib40","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/S0028-3908(96)00020-2","article-title":"Tachykinin NK1 receptor antagonists act centrally to inhibit emesis induced by the chemotherapeutic agent cisplatin in ferrets","volume":"35","author":"Tattersall","year":"1996","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bpa.2020.11.004_bib41","series-title":"Highlights of prescribing information - aprepitant","year":"2010"},{"key":"10.1016\/j.bpa.2020.11.004_bib42","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1213\/01.ane.0000263277.35140.a3","article-title":"A\u00a0randomized, double-blind comparison of the NK1 antagonist, aprepitant, versus ondansetron for the prevention of postoperative nausea and vomiting","volume":"104","author":"Gan","year":"2007","journal-title":"Anesth Analg"},{"key":"10.1016\/j.bpa.2020.11.004_bib43","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1093\/bja\/aem133","article-title":"Single-dose aprepitant vs ondansetron for the prevention of postoperative nausea and vomiting: a randomized, double-blind phase III trial in patients undergoing open abdominal surgery","volume":"99","author":"Diemunsch","year":"2007","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bpa.2020.11.004_bib44","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1185\/030079907X233115","article-title":"Preventing postoperative nausea and vomiting: post hoc analysis of pooled data from two randomized active-controlled trials of aprepitant","volume":"23","author":"Diemunsch","year":"2007","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.bpa.2020.11.004_bib45","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1213\/ANE.0b013e3181ff47e2","article-title":"A\u00a0comparison of the combination of aprepitant and dexamethasone versus the combination of ondansetron and dexamethasone for the prevention of postoperative nausea and vomiting in patients undergoing craniotomy","volume":"112","author":"Habib","year":"2011","journal-title":"Anesth Analg"},{"key":"10.1016\/j.bpa.2020.11.004_bib46","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.bjan.2020.04.005","article-title":"[Neurokinin-1 receptor antagonists for postoperative nausea and vomiting: a systematic review and meta-analysis]","volume":"70","author":"Murakami","year":"2020","journal-title":"Rev Bras Anestesiol"},{"key":"10.1016\/j.bpa.2020.11.004_bib47","doi-asserted-by":"crossref","first-page":"5703528","DOI":"10.1155\/2017\/5703528","article-title":"A\u00a0comparison of fosaprepitant and ondansetron for preventing postoperative nausea and vomiting in moderate to high risk patients: a retrospective database analysis","volume":"2017","author":"Murakami","year":"2017","journal-title":"BioMed Res Int"},{"key":"10.1016\/j.bpa.2020.11.004_bib48","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3389\/fmed.2020.00040","article-title":"Anti-emetic drugs for prophylaxis of postoperative nausea and vomiting after craniotomy: an updated systematic review and network meta-analysis","volume":"7","author":"Chen","year":"2020","journal-title":"Front Med"},{"key":"10.1016\/j.bpa.2020.11.004_bib49","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1136\/postgradmedj-2015-133515","article-title":"Aprepitant for postoperative nausea and vomiting: a systematic review and meta-analysis","volume":"92","author":"Singh","year":"2016","journal-title":"Postgrad Med"},{"key":"10.1016\/j.bpa.2020.11.004_bib50","article-title":"Neurokinin-1 receptor antagonists in preventing postoperative nausea and vomiting: a systematic review and meta-analysis","volume":"94","author":"Liu","year":"2015","journal-title":"Medicine (Baltim)"},{"key":"10.1016\/j.bpa.2020.11.004_bib51","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/PRS.0b013e31822b6932","article-title":"Aprepitant plus ondansetron compared with ondansetron alone in reducing postoperative nausea and vomiting in ambulatory patients undergoing plastic surgery","volume":"129","author":"Vallejo","year":"2012","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.bpa.2020.11.004_bib52","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s00213-014-3665-4","article-title":"The neurokinin-1 receptor antagonist aprepitant in co-morbid alcohol dependence and posttraumatic stress disorder: a human experimental study","volume":"232","author":"Kwako","year":"2015","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bpa.2020.11.004_bib53","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1093\/bja\/aes233","article-title":"Randomized, double-blind comparison of oral aprepitant alone compared with aprepitant and transdermal scopolamine for prevention of postoperative nausea and vomiting","volume":"109","author":"Green","year":"2012","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bpa.2020.11.004_bib54","doi-asserted-by":"crossref","first-page":"440","DOI":"10.4097\/kja.d.18.00011","article-title":"Aprepitant in combination with palonosetron for the prevention of postoperative nausea and vomiting in female patients using intravenous patient-controlled analgesia","volume":"71","author":"Yoo","year":"2018","journal-title":"Korean J Anesthesiol"},{"key":"10.1016\/j.bpa.2020.11.004_bib55","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/aas.13064","article-title":"Aprepitant as a fourth antiemetic prophylactic strategy in high-risk patients: a double-blind, randomized trial","volume":"62","author":"de Morais","year":"2018","journal-title":"Acta Anaesthesiol Scand"},{"key":"10.1016\/j.bpa.2020.11.004_bib56","first-page":"55","article-title":"An analysis of fosaprepitant-induced venous toxicity in patients receiving highly emetogenic chemotherapy","volume":"23","author":"Hegerova","year":"2015","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.bpa.2020.11.004_bib57","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1001\/archsurg.2010.327","article-title":"Casopitant and ondansetron for postoperative nausea and vomiting prevention in women at high risk for emesis: a phase 3 study","volume":"146","author":"Altorjay","year":"2011","journal-title":"Arch Surg"},{"key":"10.1016\/j.bpa.2020.11.004_bib58","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/ALN.0b013e3181d7b13a","article-title":"Phase II study to evaluate the safety and efficacy of the oral neurokinin-1 receptor antagonist casopitant (GW679769) administered with ondansetron for the prevention of postoperative and postdischarge nausea and vomiting in high-risk patients","volume":"113","author":"Singla","year":"2010","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bpa.2020.11.004_bib59","series-title":"Highlights of prescribing information - rolapitant","year":"2015"},{"key":"10.1016\/j.bpa.2020.11.004_bib60","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1213\/ANE.0b013e31820886c3","article-title":"Rolapitant for the prevention of postoperative nausea and vomiting: a prospective, double-blinded, placebo-controlled randomized trial","volume":"112","author":"Gan","year":"2011","journal-title":"Anesth Analg"},{"key":"10.1016\/j.bpa.2020.11.004_bib61","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1093\/bja\/aeu376","article-title":"Comparison of vestipitant with ondansetron for the treatment of breakthrough postoperative nausea and vomiting after failed prophylaxis with ondansetron","volume":"114","author":"Kranke","year":"2015","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bpa.2020.11.004_bib62","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ejphar.2012.05.037","article-title":"Inhibition of substance P-mediated responses in NG108-15 cells by netupitant and palonosetron exhibit synergistic effects","volume":"689","author":"Stathis","year":"2012","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bpa.2020.11.004_bib63","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ejphar.2013.08.049","article-title":"Molecular mechanisms of 5-HT(3) and NK(1) receptor antagonists in prevention of emesis","volume":"722","author":"Rojas","year":"2014","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bpa.2020.11.004_bib64","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1007\/s00221-014-4017-7","article-title":"Netupitant and palonosetron trigger NK1 receptor internalization in NG108-15 cells","volume":"232","author":"Thomas","year":"2014","journal-title":"Exp Brain Res"},{"key":"10.1016\/j.bpa.2020.11.004_bib65","series-title":"Highlights of prescribing information - AKYNZEO","year":"2018"},{"key":"10.1016\/j.bpa.2020.11.004_bib66","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1093\/annonc\/mdu101","article-title":"A\u00a0randomized phase III study evaluating the efficacy and safety of NEPA, a fixed-dose combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy","volume":"25","author":"Aapro","year":"2014","journal-title":"Ann Oncol"},{"key":"10.1016\/j.bpa.2020.11.004_bib67","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1093\/annonc\/mdx698","volume":"29","author":"Zhang","year":"2018","journal-title":"Ann Oncol"}],"container-title":["Best Practice & Research Clinical Anaesthesiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521689620301099?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521689620301099?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T07:50:28Z","timestamp":1776412228000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521689620301099"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":67,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S1521689620301099"],"URL":"https:\/\/doi.org\/10.1016\/j.bpa.2020.11.004","relation":{},"ISSN":["1753-3740"],"issn-type":[{"value":"1753-3740","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The next generation of antiemetics for the management of postoperative nausea and vomiting","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Anaesthesiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpa.2020.11.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}